Gender
Item
patient must be female.
boolean
C0079399 (UMLS CUI [1])
Age
Item
patient must be at least 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Tumor size TNM Breast tumor staging | Lymph node palpable Absent | Neoplasm Metastasis Absent
Item
patient's clinical stage must be documented as tumor size less than 5 cm, with no palpable nodes and no evidence of metastatic disease (t1 or t2 n0 m0)
boolean
C0475440 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C1112395 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Negative Axillary Lymph Node Ultrasonography
Item
patient must have a negative (normal) axillary ultrasound performed at siteman cancer center. lymph nodes will be evaluated based on morphologic features. aus wil be considered positive (abnormal)if lymph nodes are noted to be completely hypoechoic (absent hilum) or have focal hypoechoic cortical thickening/lobulation greater than 4 mm.
boolean
C0279781 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
Invasive carcinoma of breast
Item
patient must have a tissue diagnosis of invasive breast carcinoma
boolean
C0853879 (UMLS CUI [1])
ECOG performance status
Item
patient must have eastern cooperative oncology group (ecog) status </= 2, as documented in patient's medical record.
boolean
C1520224 (UMLS CUI [1])
Patient Available Follow-up
Item
patient must be available for follow-up.
boolean
C0030705 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
Malignant Neoplasms Previous | Criteria Fulfill | Curative treatment Malignant Neoplasms Previous | Recurrence Absent | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Surgery Carcinoma in situ of uterine cervix | Exception Surgery Lobular carcinoma in situ of breast Ipsilateral | Exception Surgery Lobular carcinoma in situ of breast Contralateral | Low Risk Cancer recurrence
Item
a patient with a history of previous malignancy is eligible for this study as long as the patient meets the following criteria for a cancer survivor. a cancer survivor is eligible provided that the following criteria are met (1) the patient has undergone potentially curative therapy for all prior malignancies; (2) there has been no evidence of recurrence (except for effectively treated basal cell or squamous carcinoma of the skin, carcinoma in-situ of the cervix that has been effectively treated by surgery alone, or lobular carcinoma in-situ of the ipsilateral or contralateral breast treated by surgery alone); and (3) the patient is deemed by their treating physician to be at low riks for recurrence from prior malignancies.
boolean
C0006826 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
C1273390 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
C0034897 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0007117 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0553723 (UMLS CUI [6,2])
C1522326 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0543467 (UMLS CUI [7,2])
C0851140 (UMLS CUI [7,3])
C1705847 (UMLS CUI [8,1])
C0543467 (UMLS CUI [8,2])
C0279563 (UMLS CUI [8,3])
C0441989 (UMLS CUI [8,4])
C1705847 (UMLS CUI [9,1])
C0543467 (UMLS CUI [9,2])
C0279563 (UMLS CUI [9,3])
C0441988 (UMLS CUI [9,4])
C3538919 (UMLS CUI [10,1])
C0920420 (UMLS CUI [10,2])
Informed Consent | Informed Consent Patient Representative
Item
patient, or the patient's legally acceptable representative, must provide a signed and date written informed consent prior to registration and any study-related procedures.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Authorization Use of Health information
Item
patient must provide written authorization to allow the use and disclosure of their protected health information. note: this may be obtained in either the study-specific informed consent or in a separate authorization form and must be obtained from the patient prior to study registration.
boolean
C0680281 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0850397 (UMLS CUI [1,3])
Patient Appropriate Sentinel Lymph Node Biopsy
Item
patient must be a candidate for sentinel lymph node biopsy (slnb).
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0796693 (UMLS CUI [1,3])
Breast Feeding | Pregnancy
Item
patient in lactating (breast-feeding) or pregnant.
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
Invasive carcinoma of breast Bilateral | Disease Multicentric
Item
patient has concurrent invasive bilateral breast malignancies or multicentric disease.
boolean
C0853879 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0439743 (UMLS CUI [2,2])
Surgery Axillary lymph nodes Ipsilateral | Excisional biopsy of lymph node | Therapeutic procedure Hidradenitis
Item
patient has had previous ipsilateral axillary surgery such as excisional biopsy of lymph nodes(s), treatment of hidradenitis.
boolean
C0543467 (UMLS CUI [1,1])
C0729594 (UMLS CUI [1,2])
C0441989 (UMLS CUI [1,3])
C0553989 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0085160 (UMLS CUI [3,2])
Appropriateness Poor Operative Surgical Procedure | Etiology Systemic disease | Exception Malignant Neoplasms
Item
patient is considered poor candidate surgical candidate due to non-malignant systemic disease.
boolean
C0814634 (UMLS CUI [1,1])
C0542537 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,3])
C0015127 (UMLS CUI [2,1])
C0442893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
Neoadjuvant Chemotherapy | Hormone Therapy | Neoadjuvant Chemotherapy Planned | Hormone Therapy Planned
Item
patient has undergone or plans to undergo neoadjuvant chemotherapy of endocrine therapy.
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2])
C0600558 (UMLS CUI [3,1])
C3665472 (UMLS CUI [3,2])
C1301732 (UMLS CUI [3,3])
C0279025 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])